These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28104232)
21. Implications of dopaminergic medication withdrawal in Parkinson's disease. Koschel J; Ray Chaudhuri K; Tönges L; Thiel M; Raeder V; Jost WH J Neural Transm (Vienna); 2022 Sep; 129(9):1169-1178. PubMed ID: 34324057 [TBL] [Abstract][Full Text] [Related]
22. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105 [TBL] [Abstract][Full Text] [Related]
29. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease]. Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669 [TBL] [Abstract][Full Text] [Related]
30. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. Samuel M; Rodriguez-Oroz M; Antonini A; Brotchie JM; Ray Chaudhuri K; Brown RG; Galpern WR; Nirenberg MJ; Okun MS; Lang AE Mov Disord; 2015 Feb; 30(2):150-9. PubMed ID: 25607799 [TBL] [Abstract][Full Text] [Related]
31. The Subthalamic Nucleus, Limbic Function, and Impulse Control. Rossi PJ; Gunduz A; Okun MS Neuropsychol Rev; 2015 Dec; 25(4):398-410. PubMed ID: 26577509 [TBL] [Abstract][Full Text] [Related]
32. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients]. Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474 [TBL] [Abstract][Full Text] [Related]
33. Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease. Cunnington AL; White L; Hood K Parkinsonism Relat Disord; 2012 Nov; 18(9):1051-2. PubMed ID: 22677468 [No Abstract] [Full Text] [Related]
34. Introduction to Parkinson disease (PD) and its complications. Marvanova M Ment Health Clin; 2016 Sep; 6(5):229-235. PubMed ID: 29955475 [TBL] [Abstract][Full Text] [Related]
35. Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors. Sierra M; Carnicella S; Strafella AP; Bichon A; Lhommée E; Castrioto A; Chabardes S; Thobois S; Krack P J Parkinsons Dis; 2015; 5(3):625-36. PubMed ID: 25870025 [TBL] [Abstract][Full Text] [Related]
36. Brain Imaging and Impulse Control Disorders in Parkinson's Disease. Roussakis AA; Lao-Kaim NP; Piccini P Curr Neurol Neurosci Rep; 2019 Aug; 19(9):67. PubMed ID: 31396719 [TBL] [Abstract][Full Text] [Related]
37. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome. Dorfman BJ; Nirenberg MJ Parkinsonism Relat Disord; 2013 Feb; 19(2):269-70. PubMed ID: 22749683 [No Abstract] [Full Text] [Related]
38. Dopamine Agonists and Impulse Control Disorders: A Complex Association. Grall-Bronnec M; Victorri-Vigneau C; Donnio Y; Leboucher J; Rousselet M; Thiabaud E; Zreika N; Derkinderen P; Challet-Bouju G Drug Saf; 2018 Jan; 41(1):19-75. PubMed ID: 28861870 [TBL] [Abstract][Full Text] [Related]
39. A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease. Chaudhuri KR; Todorova A; Nirenberg MJ; Parry M; Martin A; Martinez-Martin P; Rizos A; Henriksen T; Jost W; Storch A; Ebersbach G; Reichmann H; Odin P; Antonini A Mov Disord Clin Pract; 2015 Jun; 2(2):170-174. PubMed ID: 30713891 [TBL] [Abstract][Full Text] [Related]
40. Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus. Debove I; Paschen S; Amstutz D; Cardoso F; Corvol JC; Fung VSC; Lang AE; Martinez Martin P; Rodríguez-Oroz MC; Weintraub D; Krack P; Deuschl G; Mov Disord; 2024 Feb; 39(2):235-248. PubMed ID: 38234035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]